Related Experiment Video
Updated: Apr 7, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Changing trends in carrier screening for genetic disease in the United States
Shivani B Nazareth1, Gabriel A Lazarin1, James D Goldberg1
1Counsyl, South San Francisco, CA, USA.
Abstract:
Genetic disease is the leading cause of infant death in the United States, accounting for approximately 20% of annual infant mortality. Advances in genomic medicine and technological platforms have made possible low cost, pan-ethnic expanded genetic screening that enables obstetric care providers to offer screening for over 100 recessive genetic diseases. However, the rapid integration of genomic medicine into routine obstetric practice has raised some concerns about the practical implementation of such testing. These changing trends in carrier screening, along with concerns and potential solutions, will be addressed.
Related Concept Videos
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Pharmacogenomics: Identification of New Drug Targets
Incomplete Dominance
Karyotyping
Karyotyping
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...

